D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 63 Citations 13,609 169 World Ranking 1528 National Ranking 132

Research.com Recognitions

Awards & Achievements

Fellow of The Academy of Medical Sciences, United Kingdom

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Immune system
  • Virus

Her primary areas of investigation include Immunology, Virology, Tuberculosis, Tuberculosis vaccines and Mycobacterium tuberculosis. Her research in Vaccination, BCG vaccine, Antigen, Immunogenicity and Immune system are components of Immunology. Her studies deal with areas such as Vaccinia and ELISPOT as well as Virology.

Her research integrates issues of Heterologous, Disease and Immunity in her study of Tuberculosis. The Tuberculosis vaccines study combines topics in areas such as Internal medicine, Clinical trial and Vaccine evaluation. Helen McShane interconnects CD8 and Interferon gamma in the investigation of issues within Mycobacterium tuberculosis.

Her most cited work include:

  • Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial (729 citations)
  • Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. (528 citations)
  • Rapid Detection of Mycobacterium tuberculosis Infection by Enumeration of Antigen-specific T Cells (411 citations)

What are the main themes of her work throughout her whole career to date?

Helen McShane focuses on Immunology, Tuberculosis, Vaccination, Tuberculosis vaccines and Virology. Her Immunology study frequently draws connections between related disciplines such as Mycobacterium tuberculosis. Her work investigates the relationship between Tuberculosis and topics such as Clinical trial that intersect with problems in Pediatrics.

Her study in Vaccination is interdisciplinary in nature, drawing from both Regimen, Randomized controlled trial, Immunization, Immunity and Modified vaccinia Ankara. Her studies in Tuberculosis vaccines integrate themes in fields like Global health, Viral Vaccine and Adverse effect. Her biological study spans a wide range of topics, including Heterologous, Vaccinia, Mycobacterium bovis and Viral vector.

She most often published in these fields:

  • Immunology (70.61%)
  • Tuberculosis (60.00%)
  • Vaccination (42.45%)

What were the highlights of her more recent work (between 2018-2021)?

  • Tuberculosis (60.00%)
  • Immunology (70.61%)
  • Vaccination (42.45%)

In recent papers she was focusing on the following fields of study:

Tuberculosis, Immunology, Vaccination, Mycobacterium tuberculosis and Immune system are her primary areas of study. Her Tuberculosis research integrates issues from Clinical trial, T cell, CD8, Intensive care medicine and Nasal administration. Helen McShane studies Immunology, namely Vaccine efficacy.

Her Vaccination study combines topics from a wide range of disciplines, such as Cellular immunity, Family medicine, Lung, Antigen presentation and Parenchyma. Her research in Mycobacterium tuberculosis intersects with topics in Pathogen, Virology, Immunogenicity, Bronchoalveolar lavage and Immune protection. Her Immune system research incorporates themes from Antibody, Viral vector and Antigen.

Between 2018 and 2021, her most popular works were:

  • Nitric Oxide Modulates Metabolic Remodeling in Inflammatory Macrophages through TCA Cycle Regulation and Itaconate Accumulation (50 citations)
  • COVID-19 Vaccine Hesitancy in the UK: The Oxford Coronavirus Explanations, Attitudes, and Narratives Survey (OCEANS) II. (46 citations)
  • The Humoral Immune Response to BCG Vaccination. (33 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Immune system
  • Virus

Helen McShane mostly deals with Tuberculosis, Vaccination, Immunology, Intensive care medicine and Mycobacterium tuberculosis. The Vaccination study which covers Immune system that intersects with Viral vector, Virology and Pulmonary tb. Her Immunology study combines topics in areas such as Regimen and Adverse effect.

Her Intensive care medicine research is multidisciplinary, incorporating perspectives in Tuberculosis vaccines, Clinical trial and Licensure. The study incorporates disciplines such as Causative organism and Immune mechanisms in addition to Tuberculosis vaccines. She has included themes like Lung, Antigen presentation, Parenchyma and Nasal administration in her Mycobacterium tuberculosis study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

Michele D Tameris;Mark Hatherill;Bernard S Landry;Thomas J Scriba.
The Lancet (2013)

970 Citations

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.

Helen McShane;Ansar A Pathan;Clare R Sander;Sheila M Keating.
Nature Medicine (2004)

735 Citations

Rapid Detection of Mycobacterium tuberculosis Infection by Enumeration of Antigen-specific T Cells

Ajit Lalvani;Ansar A. Pathan;Helen McSHANE;Robert J. Wilkinson.
American Journal of Respiratory and Critical Care Medicine (2001)

728 Citations

Enhanced Immunogenicity and Protective Efficacy Against Mycobacterium tuberculosis of Bacille Calmette-Guérin Vaccine Using Mucosal Administration and Boosting with a Recombinant Modified Vaccinia Virus Ankara

Nilu P. Goonetilleke;Helen McShane;Carolyn M. Hannan;Richard J. Anderson.
Journal of Immunology (2003)

524 Citations

Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment.

Ansar A. Pathan;Katalin A. Wilkinson;Paul Klenerman;Helen McShane.
Journal of Immunology (2001)

513 Citations

Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice.

Emily K. Forbes;Clare Sander;Edward O. Ronan;Helen McShane.
Journal of Immunology (2008)

331 Citations

Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations.

Natalie E. R. Beveridge;David A. Price;David A. Price;Joseph P. Casazza;Ansar A. Pathan.
European Journal of Immunology (2007)

324 Citations

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.

Helen McShane;Helen McShane;Roger Brookes;Sarah C. Gilbert;Adrian V. S. Hill;Adrian V. S. Hill.
Infection and Immunity (2001)

312 Citations

A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans.

Matilu Mwau;Inese Cebere;Julian Sutton;Priscilla Chikoti.
Journal of General Virology (2004)

307 Citations

Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis.

H. Martin Vordermeier;Bernardo Villarreal-Ramos;Paul J. Cockle;Martin McAulay.
Infection and Immunity (2009)

277 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Helen McShane

Robert J. Wilkinson

Robert J. Wilkinson

The Francis Crick Institute

Publications: 84

Stefan H. E. Kaufmann

Stefan H. E. Kaufmann

Max Planck Institute for Infection Biology

Publications: 83

Tom H. M. Ottenhoff

Tom H. M. Ottenhoff

Leiden University Medical Center

Publications: 80

Willem A. Hanekom

Willem A. Hanekom

University College London

Publications: 80

Peter E. Andersen

Peter E. Andersen

Technical University of Denmark

Publications: 77

Thomas J. Scriba

Thomas J. Scriba

University of Cape Town

Publications: 71

Ajit Lalvani

Ajit Lalvani

Imperial College London

Publications: 64

Carlos Martín

Carlos Martín

Instituto de Salud Carlos III

Publications: 63

Adrian V. S. Hill

Adrian V. S. Hill

University of Oxford

Publications: 60

Zhou Xing

Zhou Xing

McMaster University

Publications: 58

Tomáš Hanke

Tomáš Hanke

University of Oxford

Publications: 57

Sarah C. Gilbert

Sarah C. Gilbert

University of Oxford

Publications: 56

Warwick J. Britton

Warwick J. Britton

University of Sydney

Publications: 46

Hazel M. Dockrell

Hazel M. Dockrell

London School of Hygiene & Tropical Medicine

Publications: 45

Mihai G. Netea

Mihai G. Netea

Radboud University Nijmegen

Publications: 38

Delia Goletti

Delia Goletti

Istituto Sperimentale Italiano Lazzaro Spallanzani

Publications: 37

Trending Scientists

Vincent Lepetit

Vincent Lepetit

École Normale Supérieure

M. Omair Ahmad

M. Omair Ahmad

Concordia University

Terry W. Snell

Terry W. Snell

Georgia Institute of Technology

Eitan Bibi

Eitan Bibi

Weizmann Institute of Science

Kenneth J. Lohmann

Kenneth J. Lohmann

University of North Carolina at Chapel Hill

Rupesh Chaturvedi

Rupesh Chaturvedi

Jawaharlal Nehru University

Lu Lu

Lu Lu

Fudan University

Thomas E. Cleveland

Thomas E. Cleveland

Agricultural Research Service

James E. Collins

James E. Collins

University of Minnesota

Julie Carrier

Julie Carrier

University of Montreal

Timothy R. Sterling

Timothy R. Sterling

Vanderbilt University

Salvatore Cucchiara

Salvatore Cucchiara

Sapienza University of Rome

Anssi Auvinen

Anssi Auvinen

Tampere University

Joseph H. Manson

Joseph H. Manson

University of California, Los Angeles

Mark Daniel

Mark Daniel

University of Canberra

Jie Meng

Jie Meng

Peking University

Something went wrong. Please try again later.